BrainStorm Cell Therapeutics (OTCQB: BCLI) a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that Prof. Dimitrios Karussis, Principal Investigator of the Company's clinical trials at Hadassah Medical Center in Jerusalem, will deliver an oral presentation at the 24th International Symposium on ALS/MND being held this week in Milan, Italy (http://bit.ly/IFCIdS).
Help employers find you! Check out all the jobs and post your resume.
